Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 102 participants.
Also called NCT07599982
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 102 participants
- Registry
-
NCT07599982
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07599982. Allocation not applicable; no masking; primary purpose treatment. Start 2026-05-25 (actual); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Acronym
- MODIUS
- Condition
- Type 1 Diabetes (T1D)
- Condition
- Type 2 Diabetes (T2D)
- Intervention (Device)
- MODI Algorithm
- Lead sponsor
- DreaMed Diabetes
- Collaborator
- Jaeb Center for Health Research
- Collaborator
- Abbott Diabetes Care
Record details
- Record id
cardio:ct-nct07599982- Content hash
5c549c946daed353ecb82252afa51a00e69c86411ea03b1e290cfe75dfa1c39e